These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 26059710)

  • 61. Endothelial progenitor cells as the target for cardiovascular disease prediction, personalized prevention, and treatments: progressing beyond the state-of-the-art.
    Kou F; Zhu C; Wan H; Xue F; Wang J; Xiang L; Li J
    EPMA J; 2020 Dec; 11(4):629-643. PubMed ID: 33240451
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Overexpression of the β2AR gene improves function and re-endothelialization capacity of EPCs after arterial injury in nude mice.
    Ke X; Shu XR; Wu F; Hu QS; Deng BQ; Wang JF; Nie RQ
    Stem Cell Res Ther; 2016 May; 7(1):73. PubMed ID: 27194135
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Design, preparation and performance of a novel drug-eluting stent with multiple layer coatings.
    Hu T; Lin S; Du R; Fu M; Rao Q; Yin T; Huang Y; Wang G
    Biomater Sci; 2017 Aug; 5(9):1845-1857. PubMed ID: 28676873
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Drug-eluting stent implantation could be associated with long-term coronary endothelial dysfunction.
    Shin DI; Kim PJ; Seung KB; Kim DB; Kim MJ; Chang K; Lim SM; Jeon DS; Chung WS; Baek SH; Lee MY
    Int Heart J; 2007 Sep; 48(5):553-67. PubMed ID: 17998765
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Comparison of long-term results of drug-eluting stent and bare metal stent implantation in heart transplant recipients with coronary artery disease.
    Zakliczynski M; Lekston A; Osuch M; Swierad M; Nadziakiewicz P; Przybylski R; Zembala M
    Transplant Proc; 2007 Nov; 39(9):2859-61. PubMed ID: 18022002
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials.
    Doi H; Maehara A; Mintz GS; Yu A; Wang H; Mandinov L; Popma JJ; Ellis SG; Grube E; Dawkins KD; Weissman NJ; Turco MA; Ormiston JA; Stone GW
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1269-75. PubMed ID: 20129555
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A new rapamycin-abluminally coated chitosan/heparin stent system accelerates early re-endothelialisation and improves anti-coagulant properties in porcine coronary artery models.
    Gao JQ; Zheng JP; Jin HG; Zhang WQ; Yan PY; Chen T; Liu ZJ
    Clin Invest Med; 2014 Dec; 37(6):E395-402. PubMed ID: 25618272
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Vascular endothelial growth factor (VEGF)-eluting stents: in vivo effects on thrombosis, endothelialization and intimal hyperplasia.
    Swanson N; Hogrefe K; Javed Q; Malik N; Gershlick AH
    J Invasive Cardiol; 2003 Dec; 15(12):688-92. PubMed ID: 14660819
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Short- and long-term benefits of drug-eluting stents compared to bare metal stents even in treatment for large coronary arteries.
    Yoshida T; Sakata K; Nitta Y; Taguchi T; Kaku B; Katsuda S; Shimojima M; Gamou T; Nakahashi T; Konno T; Kawashiri MA; Yamagishi M; Hayashi K
    Heart Vessels; 2016 May; 31(5):635-42. PubMed ID: 25758470
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Vascular restoration: Is there a window of opportunity?
    Sun J; Kang X; Li T
    Med Hypotheses; 2015 Dec; 85(6):972-5. PubMed ID: 26421978
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk.
    Joner M; Finn AV; Farb A; Mont EK; Kolodgie FD; Ladich E; Kutys R; Skorija K; Gold HK; Virmani R
    J Am Coll Cardiol; 2006 Jul; 48(1):193-202. PubMed ID: 16814667
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Eluting combination drugs from stents.
    Thipparaboina R; Khan W; Domb AJ
    Int J Pharm; 2013 Sep; 454(1):4-10. PubMed ID: 23850234
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The sirolimus-eluting Cypher Select coronary stent for the treatment of bare-metal and drug-eluting stent restenosis: insights from the e-SELECT (Multicenter Post-Market Surveillance) registry.
    Abizaid A; Costa JR; Banning A; Bartorelli AL; Dzavik V; Ellis S; Gao R; Holmes DR; Jeong MH; Legrand V; Neumann FJ; Nyakern M; Orlick A; Spaulding C; Worthley S; Urban PM;
    JACC Cardiovasc Interv; 2012 Jan; 5(1):64-71. PubMed ID: 22230152
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Clinical Outcomes of the Dual-Therapy CD34 Antibody-Covered Sirolimus-Eluting Stent Versus Standard Drug-Eluting Coronary Stents: A Meta-Analysis.
    Ndunda P; Vindhyal MR; Muutu T; Fanari Z
    Cardiovasc Revasc Med; 2020 Feb; 21(2):213-221. PubMed ID: 31147259
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Long-term benefit-risk balance of drug-eluting vs. bare-metal stents in daily practice: does stent diameter matter? Three-year follow-up of BASKET.
    Pfisterer M; Brunner-La Rocca HP; Rickenbacher P; Hunziker P; Mueller C; Nietlispach F; Leibundgut G; Bader F; Kaiser C;
    Eur Heart J; 2009 Jan; 30(1):16-24. PubMed ID: 19033260
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Drug-eluting stent-associated thrombosis: clinical relevance of impaired vessel-wall healing].
    Koziński M; Sukiennik A; Sinkiewicz W; Kochman W; Kubica J
    Postepy Hig Med Dosw (Online); 2008 May; 62():185-205. PubMed ID: 18464681
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Drug-Eluting Stent Design is a Determinant of Drug Concentration at the Endothelial Cell Surface.
    Seo T; Lafont A; Choi SY; Barakat AI
    Ann Biomed Eng; 2016 Feb; 44(2):302-14. PubMed ID: 26821272
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Resistant in-stent restenosis in the drug eluting stent era.
    Theodoropoulos K; Mennuni MG; Dangas GD; Meelu OA; Bansilal S; Baber U; Sartori S; Kovacic JC; Moreno PR; Sharma SK; Mehran R; Kini AS
    Catheter Cardiovasc Interv; 2016 Nov; 88(5):777-785. PubMed ID: 27184223
    [TBL] [Abstract][Full Text] [Related]  

  • 79. In vivo evaluation of a biolimus eluting nickel titanium self expanding stent with overlapping balloon expandable drug eluting and bare metal stents in a porcine coronary model.
    Cilingiroglu M; Elliott J; Sangi P; Matthews H; Tio F; Trauthen B; Elicker J; Bailey SR
    EuroIntervention; 2009 Jan; 4(4):534-41. PubMed ID: 19284078
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Histopathologic and physiologic effect of overlapping vs single coronary stents: impact of stent evolution.
    Sakamoto A; Torii S; Jinnouchi H; Virmani R; Finn AV
    Expert Rev Med Devices; 2018 Sep; 15(9):665-682. PubMed ID: 30132713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.